Literature DB >> 23050733

Association between serum ceruloplasmin levels and arterial stiffness in Korean men with type 2 diabetes mellitus.

Min Jung Lee1, Chang Hee Jung, Jenie Yoonoo Hwang, Mi Seon Shin, Ji Hee Yu, Woo Je Lee, Joong-Yeol Park.   

Abstract

BACKGROUND: Increased oxidative stress contributes to the development of arterial stiffness. Arterial stiffness, as measured by brachial-ankle pulse wave velocity (baPWV), has been known to be correlated with oxidative stress. Serum ceruloplasmin (CP), a copper-carrying protein, may indicate the overall level of oxidative stress in the body. The present study investigated whether serum CP levels are associated with baPWV in Korean men with type 2 diabetes mellitus (DM). SUBJECTS AND METHODS: Serum CP levels and conventional risk factors were measured in 760 Korean men with type 2 DM. Arterial stiffness was assessed by baPWV obtained with an automatic device (model VP-1000; Colin, Komaki, Japan).
RESULTS: Correlation analysis indicated a significant positive association between serum CP and baPWV (r = 0.109, P = 0.003). Age-adjusted baPWV increased gradually according to serum CP quartiles (Q1, 1,500.3 ± 18.4 cm/s; Q2, 1,511.6 ± 17.8 cm/s; Q3, 1,551.8 ± 17.9 cm/s; Q4, 1,622.1 ± 17.8 cm/s; P for trend < 0.001). Multivariate linear regression analysis showed that serum CP was independently associated with baPWV in various models.
CONCLUSIONS: A positive relationship was identified between CP and baPWV in adult male subjects with type 2 DM, which was independent of conventional cardiovascular risk factors. Further studies are needed to confirm whether CP contributes to the pathogenesis of increased arterial stiffness in subjects with type 2 DM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050733     DOI: 10.1089/dia.2012.0177

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  4 in total

Review 1.  EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.

Authors:  Pamela Ouyang; Sheldon H Gottlieb; Valerie L Culotta; Ana Navas-Acien
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 2.  The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.

Authors:  Xiangning Cui; Yan Wang; Han Liu; Mengjun Shi; Jingwu Wang; Yifei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

3.  Iron Together with Lipid Downregulates Protein Levels of Ceruloplasmin in Macrophages Associated with Rapid Foam Cell Formation.

Authors:  Qi Wang; Jiajie Ji; Shuangying Hao; Meng Zhang; Kuanyu Li; Tong Qiao
Journal:  J Atheroscler Thromb       Date:  2016-03-31       Impact factor: 4.928

Review 4.  An Emerging Role of Defective Copper Metabolism in Heart Disease.

Authors:  Yun Liu; Ji Miao
Journal:  Nutrients       Date:  2022-02-07       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.